1 EXHIBIT 10.42 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENT
License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Contract Type
Filed
May 15th, 1997
Company
Industry
Jurisdiction

See All (498)

EXHIBIT 10.40 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENT This Amended...
License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
Contract Type
Filed
May 15th, 1997
Company
Industry
Jurisdiction

See All (388)

ASSIGNMENT OF LICENSE AND RESTATED LICENSE AGREEMENT
License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Contract Type
Filed
May 15th, 1997
Company
Industry
Jurisdiction

See All (386)

RECITALS
Stock Subscription Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type
Filed
May 15th, 1997
Company
Industry
Jurisdiction

See All (7)

1 EXHIBIT 10.41 AMENDED AND RESTATED SUBLICENSE AGREEMENT This Amended and Restated Sublicense Agreement ("Agreement") is effective this 20 day of November, 1996, between United States Biochemical Corporation, an Ohio corporation having its principal...
Sublicense Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
Contract Type
Filed
May 15th, 1997
Company
Industry
Jurisdiction

0000950134-97-004005 Sample Contracts

Filter & Search